Ligand Pharmaceuticals LGND Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Ligand Pharmaceuticals's convertible preferred stock outstanding shares?
- Ligand Pharmaceuticals (LGND) reported convertible preferred stock outstanding shares of 0 in Q1 2026.